TR
EN
Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option?
Öz
Aim: The laser method (FiLaCTM) has recently emerged as a minimally invasive treatment option in the treatment of anal fistula. Anal incontinence and fistula recurrence after anal fistula surgery are postoperative problems that complicate the treatment. In our study, we aimed to investigate the effectiveness of the film method in the treatment of anal fistula and in which cases it should be preferred in the treatment.
Methods: Twelve patients who underwent FiLaCTM diode laser at Derik State Hospital between July 2017 and August 2018 were included in the study. Patients were analyzed retrospectively in terms of age, gender, development of incontinence, recovery and return to work, fistula types, MRI findings, and complications.
Results: 11 of the patients included in the study were male and 1 female and the mean age was 46. Intraoperative complications were not observed in any of the patients. The mean follow-up period was 13.5 (7-19) months. Complete recovery was observed in 4 (33.3%) patients in the follow-ups of the patients, while no improvement was achieved in 8 (66.7%) patients.
Conclusion: The FiLaCTM procedure for the treatment of anal fistula is a safe, minimally invasive, sphincter-sparing treatment option with low efficacy. However, it can be preferred as an initial treatment in high-level fistulas and in patients who want minimally invasive intervention.
Anahtar Kelimeler
Kaynakça
- 1. Nelson R. Anorectal abscess fistula: what do we know? Surgical Clinics. 2002; 82(6):1139-51.
- 2. Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. British Journal of Surgery. 1976; 63(1):1-12.
- 3. Zeren S, Sobutay E, Ağca B, Durmuş A, Sarı K. A retrospective study of our surgical treatment experience in perianal fistulas. Okmeydanı Journal of Medicine. 2011; 27(2):76-8.
- 4. Hall JF, Bordeianou L, Hyman N, Read T, Bartus C, Schoetz D et al. Outcomes after operations for anal fistula: results of a prospective, multicenter, regional study. Dis Colon Rectum. 2014; 57(11):1304-08.
- 5. Abramowitz L, Soudan D, Souffran M, Bouchard D, Castinel A, Suduca JM et al, for the Groupe de Recherche en Proctologie de la Société Nationale Française de Colo- Proctologie and the Club de Réflexion des Cabinets et Groupe d’Hépato- Gastroentérologie. The outcome of fistulotomy for anal fistula at 1 year: a prospective multicentre French study. Colorectal Dis. 2016; 18(3):279-85.
- 6. Garcia-Aguilar J, Belmonte C, Wong WD, Goldberg SM, Madoff RD. Anal fistula surgery. Factors associated with recurrence and incontinence. Dis Colon Rectum. 1996; 39(7):723-29.
- 7. Jordán J, Roig JV, García-Armengol J, García-Granero E, Solana A, Lledó S. Risk factors for recurrence and incontinence after anal fistula surgery. Colorectal Dis. 2010; 12(3):254-60.
- 8. Atkin GK, Martins J, Tozer P, Ranchod P, Phillips RK. For many high anal fistulas, lay open is still a good option. Tech Coloproctol. 2011; 15(2):143-50.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Klinik Tıp Bilimleri
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
28 Ağustos 2022
Gönderilme Tarihi
31 Mayıs 2022
Kabul Tarihi
19 Temmuz 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 19 Sayı: 2
APA
Yönder, H., & Tatlı, F. (2022). Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option? Harran Üniversitesi Tıp Fakültesi Dergisi, 19(2), 251-255. https://doi.org/10.35440/hutfd.1093064
AMA
1.Yönder H, Tatlı F. Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option? Harran Üniversitesi Tıp Fakültesi Dergisi. 2022;19(2):251-255. doi:10.35440/hutfd.1093064
Chicago
Yönder, Hüseyin, ve Faik Tatlı. 2022. “Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option?”. Harran Üniversitesi Tıp Fakültesi Dergisi 19 (2): 251-55. https://doi.org/10.35440/hutfd.1093064.
EndNote
Yönder H, Tatlı F (01 Ağustos 2022) Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option? Harran Üniversitesi Tıp Fakültesi Dergisi 19 2 251–255.
IEEE
[1]H. Yönder ve F. Tatlı, “Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option?”, Harran Üniversitesi Tıp Fakültesi Dergisi, c. 19, sy 2, ss. 251–255, Ağu. 2022, doi: 10.35440/hutfd.1093064.
ISNAD
Yönder, Hüseyin - Tatlı, Faik. “Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option?”. Harran Üniversitesi Tıp Fakültesi Dergisi 19/2 (01 Ağustos 2022): 251-255. https://doi.org/10.35440/hutfd.1093064.
JAMA
1.Yönder H, Tatlı F. Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option? Harran Üniversitesi Tıp Fakültesi Dergisi. 2022;19:251–255.
MLA
Yönder, Hüseyin, ve Faik Tatlı. “Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option?”. Harran Üniversitesi Tıp Fakültesi Dergisi, c. 19, sy 2, Ağustos 2022, ss. 251-5, doi:10.35440/hutfd.1093064.
Vancouver
1.Hüseyin Yönder, Faik Tatlı. Is FiLaCTM the Ideal Choice for Initial Treatment of Anal Fistula as a Minimally Invasive Treatment Option? Harran Üniversitesi Tıp Fakültesi Dergisi. 01 Ağustos 2022;19(2):251-5. doi:10.35440/hutfd.1093064